| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.008 |